1. Home
  2. KOPN vs PMVP Comparison

KOPN vs PMVP Comparison

Compare KOPN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

N/A

Current Price

$2.29

Market Cap

424.9M

Sector

Technology

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.11

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOPN
PMVP
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.9M
68.9M
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
KOPN
PMVP
Price
$2.29
$1.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.25
$5.00
AVG Volume (30 Days)
2.8M
255.3K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,602,295.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.02
N/A
52 Week Low
$0.71
$0.81
52 Week High
$4.16
$1.84

Technical Indicators

Market Signals
Indicator
KOPN
PMVP
Relative Strength Index (RSI) 39.08 33.18
Support Level $2.40 $1.14
Resistance Level $2.44 $1.30
Average True Range (ATR) 0.19 0.07
MACD 0.01 -0.01
Stochastic Oscillator 11.48 2.08

Price Performance

Historical Comparison
KOPN
PMVP

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Share on Social Networks: